SCHEMBL23903104

SCHEMBL23903104

O=c1c2ccccc2oc2nc3cc4c(cc3n12)[nH]c1ccccc14

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.54
RAB9A P51151 1/20 0.54
AHR P35869 1/20 0.40
CDC25B P30305 1/20 0.38
TOP2A P11388 1/20 0.38
GABRP O00591 6/20 0.38
GABRD O14764 6/20 0.38
GABRA1 P14867 6/20 0.38
GABRB1 P18505 6/20 0.38
GABRG2 P18507 6/20 0.38
GABRB3 P28472 6/20 0.38
GABRA5 P31644 6/20 0.38
GABRA3 P34903 6/20 0.38
GABRA2 P47869 6/20 0.38
GABRB2 P47870 6/20 0.38
GABRA4 P48169 6/20 0.38
GABRE P78334 6/20 0.38
GABRA6 Q16445 6/20 0.38
GABRG1 Q8N1C3 6/20 0.38
GABRG3 Q99928 6/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23902934 0.85 NPC1 (0.51) NPC1RAB9AGABRA1GABRG2GABRB3
SCHEMBL20561245 0.81 NPC1 (0.51) NPC1RAB9AAHRTOP2AGABRP
SCHEMBL29697227 0.81 NPC1 (0.51) NPC1RAB9AAHRTOP2AGABRP
SCHEMBL23902879 0.79 NPC1 (0.41) NPC1RAB9A
SCHEMBL23903106 0.79 AHR (0.45) AHRCDC25BTOP2ACYP1A2CYP1A1
SCHEMBL23903178 0.79 NPC1 (0.60) NPC1RAB9AAHRCYP1A2
SCHEMBL25501209 0.79 RAB9A (0.54) NPC1RAB9A
SCHEMBL23902877 0.79 NPC1 (0.48) NPC1RAB9ACDC25BGABRPGABRD
SCHEMBL26227038 0.77 NPC1 (0.62) NPC1RAB9AAHRGABRPGABRD
SCHEMBL26226874 0.76 NPC1 (0.78) NPC1RAB9AGABRPGABRDGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151026-A1 MULTI-LAYER BODY FOR DIFFUSE TRANSILLUMINATION MERCK PATENT GMBH (DE) 2023-05-18 US disclosed
US-20230151026-A1 MULTI-LAYER BODY FOR DIFFUSE TRANSILLUMINATION MERCK PATENT GMBH (DE) 2023-05-18 US disclosed
WO-2021198213-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2021-10-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151026-A1 MULTI-LAYER BODY FOR DIFFUSE TRANSILLUMINATION DDT, EPCAM, SLC18A3 NPC1 1782/4885RAB9A 1937/4885AHR 2896/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.